マーケットレポート詳細

調査カテゴリ

サイト内検索

お探しの資料等をキーワード検索できます。英語検索も有効です。

がん診断用AI（人工知能）の世界市場：2031年予測

AI in Cancer Diagnostics Market (Component: Software Solutions and Services; Cancer Type: Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版元：Transparency Market Research　出版元について
発行年：2023年　8月
定価：Single User License(1名様ライセンス)US$5,795(米国ドル)/　Multi User License　$8,795 /　Corporate User License $11,795
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算（お見積り日TTSレート）となります。
納品形態：PDF by Email
当調査レポートは英文　153ページになります。
商品コード：TMR067

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

がん診断用AI（人工知能）の世界市場規模は2022年で8億5900万ドル、2031年に20億ドル、市場の平均年成長率は11.2%で成長が続く見通しです。

がんの有病率の上昇と、がんの早期診断に関する意識の高まりが、がん診断用AI市場を牽引しています。がん診断とAI技術の統合は、精度、効率、治療実績を改善しており、有望な結果を示しているといえるでしょう。オーダーメイドの治療計画を導くパターンや相関関係を特定する、AIアルゴリズムを用いた個別化治療戦略の開発は、近い将来がん診断用AI市場規模を促進する可能性があります。

当レポートでは、がん診断用AI（人工知能）の市場予測-2031年、各種セグメント別市場分析(がん種類別、用途別、国地域別、等)、成長要因、競合状況、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

■がん診断用AI（人工知能）の世界市場予測2017-2031年

・市場規模(US$)

■コンポーネント別、市場-2031年

ソフトウェア・ソリューション
サービス
※(市場規模US$)

■がん種類別、市場-2031年

乳がん
前立腺がん
肺がん
大腸がん
子宮頸がん
その他
※(市場規模US$)

■用途別、市場-2031年

スクリーニングと診断
腫瘍同定
モニタリング
※(市場規模US$)

■エンドユーザー別、市場-2031年

病院
診断センター
医療研究機関
受託研究機関
※(市場規模US$)

■主要国地域別市場-2031年

北米
・米国、カナダ
欧州
・英国、ドイツ、フランス、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
南米
・ブラジル、メキシコ
・その他南米
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析

市場ドライバー、障壁
市場考察
主要なソフトウェアリスト
市場シェア
競合状況

■がん診断用AI（人工知能）の主要企業プロフィール動向

Ibex Medical Analytics
EarlySign
Cancer Center.ai
Microsoft
Flatiron
Path AI
Therapixel
Tempus
Paige AI, Inc.
Kheiron Medical Technologies Limited
SkinVision
Freenome
Whiterabbit.ai
Mindpeak GmbH

（全153頁）

【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次）

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global AI in Cancer Diagnostics Market

4. Market Overview

4.1. Introduction
4.1.1. Component Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global AI in Cancer Diagnostics Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Different Technique Overview of Machine Learning in Oncology
5.2. Technological Advancements
5.3. List of Major Software used as AI in Cancer Diagnostics
5.4. Regulatory Scenario by Region/Globally
5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global AI in Cancer Diagnostics Market Analysis and Forecast, by Component

6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Component, 2017-2031
6.3.1. Software Solutions
6.3.2. Services
6.4. Market Attractiveness Analysis, by Component

7. Global AI in Cancer Diagnostics Market Analysis and Forecast, by Cancer Type

7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Cancer Type, 2017-2031
7.3.1. Breast Cancer
7.3.2. Prostate Cancer
7.3.3. Lung Cancer
7.3.4. Colorectal Cancer
7.3.5. Cervical Cancer
7.3.6. Others
7.4. Market Attractiveness Analysis, by Cancer Type

8. Global AI in Cancer Diagnostics Market Analysis and Forecast, by Application

8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017-2031
8.3.1. Screening & Diagnosis
8.3.2. Tumor Identification
8.3.3. Monitoring
8.4. Market Attractiveness Analysis, by Application

9. Global AI in Cancer Diagnostics Market Analysis and Forecast, by End-user

9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals
9.3.2. Diagnostic Centers
9.3.3. Medical Research Institutes
9.3.4. Contract Research Organizations
9.4. Market Attractiveness Analysis, by End-user

10. Global AI in Cancer Diagnostics Market Analysis and Forecast, by Region

10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017-2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region

11. North America AI in Cancer Diagnostics Market Analysis and Forecast

11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Component, 2017-2031
11.2.1. Software Solutions
11.2.2. Services
11.3. Market Value Forecast, by Cancer Type, 2017-2031
11.3.1. Breast Cancer
11.3.2. Prostate Cancer
11.3.3. Lung Cancer
11.3.4. Colorectal Cancer
11.3.5. Cervical Cancer
11.3.6. Others
11.4. Market Value Forecast, by Application, 2017-2031
11.4.1. Screening & Diagnosis
11.4.2. Tumor Identification
11.4.3. Monitoring
11.5. Market Value Forecast, by End-user, 2017-2031
11.5.1. Hospitals
11.5.2. Diagnostic Centers
11.5.3. Medical Research Institutes
11.5.4. Contract Research Organizations
11.6. Market Value Forecast, by Country, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Component
11.7.2. By Cancer Type
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country

12. Europe AI in Cancer Diagnostics Market Analysis and Forecast

12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Component, 2017-2031
12.2.1. Software Solutions
12.2.2. Services
12.3. Market Value Forecast, by Cancer Type, 2017-2031
12.3.1. Breast Cancer
12.3.2. Prostate Cancer
12.3.3. Lung Cancer
12.3.4. Colorectal Cancer
12.3.5. Cervical Cancer
12.3.6. Others
12.4. Market Value Forecast, by Application, 2017-2031
12.4.1. Screening & Diagnosis
12.4.2. Tumor Identification
12.4.3. Monitoring
12.5. Market Value Forecast, by End-user, 2017-2031
12.5.1. Hospitals
12.5.2. Diagnostic Centers
12.5.3. Medical Research Institutes
12.5.4. Contract Research Organizations
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Component
12.7.2. By Cancer Type
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region

13. Asia Pacific AI in Cancer Diagnostics Market Analysis and Forecast

13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Component, 2017-2031
13.2.1. Software Solutions
13.2.2. Services
13.3. Market Value Forecast, by Cancer Type, 2017-2031
13.3.1. Breast Cancer
13.3.2. Prostate Cancer
13.3.3. Lung Cancer
13.3.4. Colorectal Cancer
13.3.5. Cervical Cancer
13.3.6. Others
13.4. Market Value Forecast, by Application, 2017-2031
13.4.1. Screening & Diagnosis
13.4.2. Tumor Identification
13.4.3. Monitoring
13.5. Market Value Forecast, by End-user, 2017-2031
13.5.1. Hospitals
13.5.2. Diagnostic Centers
13.5.3. Medical Research Institutes
13.5.4. Contract Research Organizations
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Component
13.7.2. By Cancer Type
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region

14. Latin America AI in Cancer Diagnostics Market Analysis and Forecast

14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Component, 2017-2031
14.2.1. Software Solutions
14.2.2. Services
14.3. Market Value Forecast, by Cancer Type, 2017-2031
14.3.1. Breast Cancer
14.3.2. Prostate Cancer
14.3.3. Lung Cancer
14.3.4. Colorectal Cancer
14.3.5. Cervical Cancer
14.3.6. Others
14.4. Market Value Forecast, by Application, 2017-2031
14.4.1. Screening & Diagnosis
14.4.2. Tumor Identification
14.4.3. Monitoring
14.5. Market Value Forecast, by End-user, 2017-2031
14.5.1. Hospitals
14.5.2. Diagnostic Centers
14.5.3. Medical Research Institutes
14.5.4. Contract Research Organizations
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Component
14.7.2. By Cancer Type
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region

15. Middle East & Africa AI in Cancer Diagnostics Market Analysis and Forecast

15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Component, 2017-2031
15.2.1. Software Solutions
15.2.2. Services
15.3. Market Value Forecast, by Cancer Type, 2017-2031
15.3.1. Breast Cancer
15.3.2. Prostate Cancer
15.3.3. Lung Cancer
15.3.4. Colorectal Cancer
15.3.5. Cervical Cancer
15.3.6. Others
15.4. Market Value Forecast, by Application, 2017-2031
15.4.1. Screening & Diagnosis
15.4.2. Tumor Identification
15.4.3. Monitoring
15.5. Market Value Forecast, by End-user, 2017-2031
15.5.1. Hospitals
15.5.2. Diagnostic Centers
15.5.3. Medical Research Institutes
15.5.4. Contract Research Organizations
15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Component
15.7.2. By Cancer Type
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player - Competition Matrix, by tier and size of companies
16.2. Market Share Analysis, by Company, 2022
16.3. Company Profiles
16.3.1. Ibex Medical Analytics
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. EarlySign
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Cancer Center.ai
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Microsoft
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Flatiron
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Path AI
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Therapixel
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Tempus
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Paige AI, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Kheiron Medical Technologies Limited
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. SkinVision
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. Freenome
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview
16.3.13. Whiterabbit.ai
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Product Portfolio
16.3.13.3. Financial Overview
16.3.13.4. SWOT Analysis
16.3.13.5. Strategic Overview
16.3.14. Mindpeak GmbH
16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.14.2. Product Portfolio
16.3.14.3. Financial Overview
16.3.14.4. SWOT Analysis
16.3.14.5. Strategic Overview

List of Tables

Table 01: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031

Table 02: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031

Table 03: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 04: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 05: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 06: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031

Table 07: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031

Table 08: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 09: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 10: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2031

Table 11: Europe AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031

Table 12: Europe AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031

Table 13: Europe AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 14: Europe AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 15: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 16: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031

Table 17: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031

Table 18: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 19: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 20: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 21: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031

Table 22: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031

Table 23: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 24: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 25: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 26: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031

Table 27: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031

Table 28: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 29: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

Figure 01: Global AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031

Figure 02: Global AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031

Figure 03: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Software Solutions, 2017-2031

Figure 04: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Services, 2017-2031

Figure 05: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031

Figure 06: Global AI in Cancer Diagnostics Market Attractiveness Analysis, by Cancer Type, 2023-2031

Figure 07: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Breast Cancer, 2017-2031

Figure 08: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Prostate Cancer, 2017-2031

Figure 09: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Lung Cancer, 2017-2031

Figure 10: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Colorectal Cancer, 2017-2031

Figure 11: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Cervical Cancer, 2017-2031

Figure 12: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Others, 2017-2031

Figure 13: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Figure 14: Global AI in Cancer Diagnostics Market Attractiveness Analysis, Application, 2023-2031

Figure 15: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Screening & Diagnosis, 2017-2031

Figure 16: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Tumor Identification, 2017-2031

Figure 17: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Monitoring, 2017-2031

Figure 18: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Figure 19: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Figure 20: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Hospitals, 2017-2031

Figure 21: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Diagnostic Centers, 2017-2031

Figure 22: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Medical Research Institutes, 2017-2031

Figure 23: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Contract Research Organizations, 2017-2031

Figure 24: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2031

Figure 25: Global AI in Cancer Diagnostics Market Attractiveness Analysis, by Region, 2023-2031

Figure 26: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2031

Figure 27: North America AI in Cancer Diagnostics Market Value Share Analysis, by Country, 2022 and 2031

Figure 28: North America AI in Cancer Diagnostics Market Attractiveness Analysis, by Country, 2023-2031

Figure 29: North America AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031

Figure 30: North America AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031

Figure 31: North America AI in Cancer Diagnostics Market Value Share Analysis, by Cancer Type, 2022 and 2031

Figure 32: North America AI in Cancer Diagnostics Market Attractiveness Analysis, Cancer Type, 2023-2031

Figure 33: North America AI in Cancer Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

Figure 34: North America AI in Cancer Diagnostics Market Attractiveness Analysis, by Application, 2023-2031

Figure 35: North America AI in Cancer Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

Figure 36: North America AI in Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

Figure 37: Europe AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2031

Figure 38: Europe AI in Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 39: Europe AI in Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 40: Europe AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031

Figure 41: Europe AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031

Figure 42: Europe AI in Cancer Diagnostics Market Value Share Analysis, by Cancer Type, 2022 and 2031

Figure 43: Europe AI in Cancer Diagnostics Market Attractiveness Analysis, by Cancer Type, 2023-2031

Figure 44: Europe AI in Cancer Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

Figure 45: Europe AI in Cancer Diagnostics Market Attractiveness Analysis, by Application, 2023-2031

Figure 46: Europe AI in Cancer Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

Figure 47: Europe AI in Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

Figure 48: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2031

Figure 49: Asia Pacific AI in Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 50: Asia Pacific AI in Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 51: Asia Pacific AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031

Figure 52: Asia Pacific AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031

Figure 53: Asia Pacific AI in Cancer Diagnostics Market Value Share Analysis, by Cancer Type, 2022 and 2031

Figure 54: Asia Pacific AI in Cancer Diagnostics Market Attractiveness Analysis, by Cancer Type, 2023-2031

Figure 55: Asia Pacific AI in Cancer Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

Figure 56: Asia Pacific AI in Cancer Diagnostics Market Attractiveness Analysis, by Application, 2023-2031

Figure 57: Asia Pacific AI in Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

Figure 58: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2031

Figure 59: Latin America AI in Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 60: Latin America AI in Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 61: Latin America AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031

Figure 62: Latin America AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031

Figure 63: Latin America AI in Cancer Diagnostics Market Value Share Analysis, by Cancer Type, 2022 and 2031

Figure 64: Latin America AI in Cancer Diagnostics Market Attractiveness Analysis, Cancer Type, 2023-2031

Figure 65: Latin America AI in Cancer Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

Figure 66: Latin America AI in Cancer Diagnostics Market Attractiveness Analysis, by Application, 2023-2031

Figure 67: Latin America AI in Cancer Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

Figure 68: Latin America AI in Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

Figure 69: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2031

Figure 70: Middle East & Africa AI in Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 71: Middle East & Africa AI in Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 72: Middle East & Africa AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031

Figure 73: Middle East & Africa AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031

Figure 74: Middle East & Africa AI in Cancer Diagnostics Market Value Share Analysis, by Cancer Type, 2022 and 2031

Figure 75: Middle East & Africa AI in Cancer Diagnostics Market Attractiveness Analysis, Cancer Type, 2023-2031

Figure 76: Middle East & Africa AI in Cancer Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

Figure 77: Middle East & Africa AI in Cancer Diagnostics Market Attractiveness Analysis, by Application, 2023-2031

Figure 78: Middle East & Africa AI in Cancer Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

Figure 79: Middle East & Africa AI in Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

Figure 80: Global AI in Cancer Diagnostics Market Share Analysis, by Company 2022

△ 一番上に戻る